Rapid TEG treatment algorithm from Houston
| Rapid TEG variables . | Normal range . | Patient value . | Coagulopathy . | Hemostatic therapy . |
|---|---|---|---|---|
| ATC | 86-118 seconds | >128 seconds | Coagulation factors ↓ | Plasma and RBCs |
| R | 0-1 minutes | >1.1 minutes | Coagulation factors ↓ | Plasma and RBCs |
| K | 1-2 minutes | >2.5 minutes | Fibrinogen ↓ | Cryoprecipitate/fibrinogen/plasma |
| Angle | 66-82° | <56° | Fibrinogen ↓ | Cryoprecipitate/fibrinogen/plasma |
| MA | 54-72 mm | <55 mm | Platelets ↓/fibrinogen ↓ | Platelets/cryoprecipitate/fibrinogen |
| Ly30 | 0-7.5% | >3% | Hyperfibrinolysis | Tranexamic acid* |
| Rapid TEG variables . | Normal range . | Patient value . | Coagulopathy . | Hemostatic therapy . |
|---|---|---|---|---|
| ATC | 86-118 seconds | >128 seconds | Coagulation factors ↓ | Plasma and RBCs |
| R | 0-1 minutes | >1.1 minutes | Coagulation factors ↓ | Plasma and RBCs |
| K | 1-2 minutes | >2.5 minutes | Fibrinogen ↓ | Cryoprecipitate/fibrinogen/plasma |
| Angle | 66-82° | <56° | Fibrinogen ↓ | Cryoprecipitate/fibrinogen/plasma |
| MA | 54-72 mm | <55 mm | Platelets ↓/fibrinogen ↓ | Platelets/cryoprecipitate/fibrinogen |
| Ly30 | 0-7.5% | >3% | Hyperfibrinolysis | Tranexamic acid* |
Goal-directed Rapid TEG–based guideline for hemostatic resuscitation with plasma, platelets, cryoprecipitate, fibrinogen, and tranexamic acid in bleeding patients used at Memorial Hermann Hospital, Houston. ACT, activated clotting time.
If time from injury is <3 hours and patient is bleeding.